SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-08-020491
Filing Date
2008-03-28
Accepted
2008-03-28 08:00:31
Documents
6
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a08-9280_110k.htm 10-K 1327624
2 EX-23.1 a08-9280_1ex23d1.htm EX-23.1 3943
3 EX-31.1 a08-9280_1ex31d1.htm EX-31.1 13766
4 EX-31.2 a08-9280_1ex31d2.htm EX-31.2 15343
5 EX-32.1 a08-9280_1ex32d1.htm EX-32.1 8172
6 EX-32.2 a08-9280_1ex32d2.htm EX-32.2 10492
  Complete submission text file 0001104659-08-020491.txt   1380884
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15070 | Film No.: 08716771
SIC: 2834 Pharmaceutical Preparations